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The purpose of this study was to describe the frequency and types of complications after 
tube thoracostomy (TT) among all patients treated with TT for both traumatic and non-
traumatic indications. 
 
This was a retrospective register-based study of patients treated with TT between the 
years 2004-2014 in Southwest Finland hospital district. 
 
1808 patients who had undergone TT were identified, complete data on TT treatment 
was available for 1169 patients. 233 (19.9%) patients had 289 complications, 284 
(98.3%) were positional resulting in tube malfunction. In 84 (7.2%) patients malposition 
of the tube resulted in need for non-urgent operative treatment. There were 103 in-
hospital deaths, but none due to TT complications. Empyema as a treatment indication 
was more frequent in patients with complications (15,9% vs 6,8%, p<0.001) as was 
diabetes (21,9% vs 13,2%, p=0.001). The likelihood of complications was lower with 
CH16 tubes (OR 0.22, p<0.001) and higher in diabetics (OR 1.86, p=0.001). 
 
Tube thoracostomy is a common procedure and complications occur in 19.9% of 
patients. Serious complications caused by the chest tube placement, however, are 
extremely rare. Complications were most common in patients treated for empyema and 
diabetics. Small CH16 tubes were associated with a lower incidence of complications. 
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Abstract 
 
Background and Aims: The purpose of this study was to describe the frequency and types of 
complications after tube thoracostomy (TT) among all patients treated with TT for both traumatic 
and non-traumatic indications.  
 
Material and Methods: Retrospective register-based study of patients treated with TT between the 
years 2004-2014 in a university hospital. 
 
Results: 1808 patients who had undergone TT were identified, complete data on TT treatment was 
available for 1169 patients. 233 (19.9%) patients had 289 complications, 284 (98.3%) were 
positional resulting in tube malfunction. In 84 (7.2%) patients malposition of the tube resulted in 
need for non-urgent operative treatment. There were 103 in-hospital deaths, but none due to TT 
complications. Empyema as a treatment indication was more frequent in patients with 
complications (15,9% vs 6,8%, p<0.001) as was diabetes (21,9% vs 13,2%, p=0.001). The 
likelihood of complications was lower with CH16 tubes (OR 0.22, p<0.001) and higher in diabetics 
(OR 1.86, p=0.001). 
 
Conclusions: Tube thoracostomy is a common procedure and complications occur in 19.9% of 
patients. Serious complications caused by the chest tube placement, however, are extremely rare. 
Complications were most common in patients treated for empyema and diabetics. Small CH16 
tubes were associated with a lower incidence of complications. 
 
Keywords: chest tube, thoracostomy, complications, pneumothorax, hemothorax, pleural effusion, 
pleural empyema 
 
Introduction 
 
Tube thoracostomy (TT) as a treatment to remove excessive material from the pleural cavity has 
been known already for thousands of years. The oldest known documents of TT are from the fifth 
century BCE. Hippocrates is attributed as the first person to treat a patient with TT and successfully 
managed to treat inflammation with this procedure.(1)  TT is at present an ubiquitous treatment for 
example for pneumothorax, hemothorax, hemopneumothorax, pleural empyema and pleural 
effusions. Although thoracostomy has been known for a long time, it was generally accepted as a 
treatment for the above-mentioned conditions as late as in the late 1950s.(1) Currently TT is one of 
the most commonly performed invasive therapeutic procedures.(2)  
 
Despite its relative safety and ease as a procedure it can lead to potentially severe complications. In 
previous studies the complication rates have been reported as high as 40%, ranging from 1-40%.(3) 
(4) (5) (6) Most of the existing literature focuses on outcomes in trauma patients.(4) (6) The 
purpose of this study was to describe the frequency and types of complications of TT among all 
patients treated with TT for both traumatic and non-traumatic indications.  
 
 
Material and Methods 
 
The study was a retrospective register-based study. Consecutive patients treated with TT between 
the years 2004-2014 in a hospital Southwestern Finland Hospital District were identified from 
patient records and operative logs. Patients receiving TT were identified by the procedural codes 
(NOMESCO code GAA10). Patients receiving a postoperative chest tube after a thoracic or cardiac 
operation were excluded and data on thoracostomy patients dying outside the hospital (for example 
emergency treatment in the field or patients treated at primary health care facilities) could not be 
retrieved for this study. Also bedside TT:s in the ICU and other intensive care units are not 
necessarily assigned procedure codes in the patient records and could thus not be identified. Based 
on the criteria 1808 patients were identified. The study flow chart is presented in Figure 1. Of the 
1808 patients 497 were excluded due to incomplete or unclear patient records or incorrect coding of 
the procedure or diagnosis. 230 of these 497 patients had received a tube and the total number of 
1419 tubes was used to estimate the yearly incidence of tube thoracostomies. 142 of the selected 
subjects had a postoperative tube after a thoracic or cardiac operation due to inaccurate coding. The 
final patient population used for outcome analyses was 1169 patients.  
 
Figure 1. Study flow chart 
 
 
Patient records were reviewed for baseline characteristics and perioperative data (table 1-2.).  
Indications for placement were grouped into malignancies, traumas, iatrogenic complications (e.g. 
central venous line placement complication), spontaneous pneumothoraxes, empyema or 
parapneumonic effusions, pleural effusions and other. Urgency was classified as elective or urgent. 
Cases where the procedure was planned and postponed for the following or any later date were 
classified as elective and all other cases as urgent. Physician specialties were cardiothoracic, other 
surgical, anesthesia, emergency medicine, radiology, pulmonology, other, resident physician and 
unknown. The category “other” included other specialties, physicians with no specialty and medical 
students. Chest tube size was registered as French (Fr). Placement site was classified as anterior 
axillary, mid axillary, posterior axillary, anterior mid clavicular and unknown.  
Bleeding disorder, smoking, diabetes, COPD, asthma and antithrombotic medication 
were registered as pertinent history relating to TT complications. Recorded 
antithrombotic/anticoagulant drugs were warfarin, heparin or low molecular weight heparin 
(LMWH), clopidogrel, ASA and other antithrombotics. If there was no clear mention of smoking 
cessation, the patient was defined as a smoker. COPD was defined as a diagnosis of chronic lung 
disease in the patient records. Diabetes (type 1 and 2) was based on a diagnosis in patient records.  
Aho et al generated a standardized format for reporting TT complications. They 
grouped complications into five clearly defined categories: insertional, positional, 
infective/immunologic, removal and instructional/educational/equipment related.(7) The same 
grouping was used in this study. Insertional complications were complications occurring within 24 
hours and were further divided into malposition, perforation of organ, bleeding requiring 
transfusion, intractable pain and need for operative intervention. Positional complications were 
complications occurring after 24 hours and were classified as need for operative intervention, need 
for new tube (obstruction, inadequate drainage of liquid or blood) and prolonged air leak. Prolonged 
air leak was defined as air leak >7 days post-insertion. Operative intervention included any 
procedure performed under general anesthesia. 
 
Categorical variables were presented as numbers and proportions and continuous variables as mean 
and standard deviation. Between groups differences were evaluated with Chi-square-test for 
categorical variables and independent samples T-test for continuous variables. Independent 
predictors of complications were evaluated with binary multivariable logistic regression analysis. 
Variables with a p-value <0.10 on univariable analysis were entered in the multivariable model. P-
values under 0,05 were considered statistically significant. SPSS for mac version 24 (IBM Armonk, 
NY, USA) was used for analyses. 
 
 
Results 
 
Baseline characteristics 
 
Baseline characteristics are shown in Table 1. The patient population used for analyses was 1169. 
Mean age of the population was 60.5 years and the age distribution were 1-98 years. 31.8% of the 
subjects were smokers. Diabetes was present in 15.0%, COPD 11.2% and asthma in 7.2%. There 
were no patients with known bleeding disorders. 21.0% patients had one or more ongoing 
anticoagulant or antithrombotic medication.). Diabetes was more prevalent in patients with 
complications compared to patients without complications (21.9% vs 13.2%, p<0.001). 
 
Table 1. Baseline characteristics 
    All Complication 
No 
Complication p-value 
Total [n (%)]   
1169 
(100.0) 233 (100.0) 936 (100.0) 0.148 
Age [mean (± sd)]. years   60.5 (19.2) 60.2 (19.1) 60.6 (19.2) 0.967 
Gender [n (%)]       
 Male   699 (59.8) 149 (63.9) 550 (58.8) 0.148 
 Female   470 (40.2) 84 (36.1) 386 (41.2) 0.148 
Comorbidities and medications [n (%)]     
 Smoking   372 (31.8) 72 (30.9) 300 (32.1) 0.736 
 Diabetes   175 (15.0) 51 (21.9) 124 (13.2) 0.001 
 COPD 
(med)   131 (11.2) 22 (9.4) 109 (11.6) 0.340 
 Asthma (med)  84 (7.2) 16 (6.9) 68 (7.3) 0.833 
 Warfarin   45 (3.8) 9 (3.9) 36 (3.8) 0.991 
 Heparin/LMWH  95 (8.1) 16 (6.9) 79 (8.3) 0.432 
 Clopidogrel   7 (0.6) 2 (0.9) 5 (0.5) - 
 ASA   132 (11.3) 24 (10.3) 108 (11.5) 0.593 
 Other anticoagulant/antithrombotic 5 (0.4) 1 (0.4) 4 (0.4) - 
 Some anticoagulant/antithrombotic 245 (21.0) 45 (19.4) 200 (21.5) 0.490 
 Bleeding disorder  0 0 0 - 
 
 
Operative and baseline data 
 
Operative and baseline data is shown in Table 2. Most of the TT:s were performed by 
pulmonologists in 40.5% of subjects. Resident physicians performed 26.2% and cardiothoracic 
surgeons 14.4% of procedures. Anesthesiologists, emergency physicians, radiologists, and other 
physicians were a minority of performing physicians. Specialty of the treating physician was 
unknown in 6.4% of patients. 
Tube size varied between 8 and 32 Fr. 16 Fr tubes were the most common size (40.5% of subjects). 
In 34.1% of the cases tube size was not recorded. 
33.4% of the tubes were placed in the posterior axillary and 22.9% in the midaxillary position. 
Anterior axillary placements were done in 2.6% cases and anterior midclavicular only in 0.5% 
patients. 40.5% of the placements were not clearly specified in the records. 
Malignant effusions were the most common indication for tube thoracostomy with 37.6% subjects. 
Other indications in descending order of frequency were trauma, benign effusion, pneumothorax, 
empyema, pneumonia, iatrogenic and infection. There was a statistically significant difference in 
indications for tube placement between groups. Patients who experienced a complications were 
more likely to have empyema or parapneumonic effusion as an indication for the procedure (p=0). 
Most of the TT placements were urgent, 87.1%. 2.7% subjects received bilateral tubes and 2.2% of 
the tubes were inserted under ultrasound guidance. 
Data on treatment duration was retrieved for 67.3% and data on length of stay for 89.6% patients. 
The mean tube treatment duration was 6 days and hospital stay was 10 days. The longest treatment 
duration was 43 days.  
 
Table 2. Operative and baseline data 
    All Complication 
No 
Complication p-value 
Total [n (%)]  
1169 
(100.0) 233 (100.0) 936 (100.0) 0.148 
Physician specialty [n (%)]      
 Cardiothoracic  168 (14.4) 40 (17.2) 128 (13.7) 0.174 
 Other surgical  100 (8.6) 29 (12.4) 71 (7.6) 0.018 
 Anesthesia   5 (0.4) 1 (0.4) 4 (0.4) - 
 Emergency medicine  10 (0.9) 3 (1.3) 7 (0.7) 0.423 
 Radiology   24 (2.1) 3 (1.3) 21 (2.2) 0.357 
 Pulmonology   473 (40.5) 76 (32.6) 397 (42.4) 0.006 
 Other   8 (0.7) 1 (0.4) 7 (0.7) - 
 Resident physician  306 (26.2) 67 (28.8) 239 (25.5) 0.317 
 Unknown   75 (6.4) 13 (5.6) 62 (6.6) - 
Tube size [n (%)]       
 8   25 (2.1) 4 (1.7) 21 (2.2) 0.557 
 12   8 (0.7) 2 (0.9) 6 (0.6) - 
 16   473 (40.5) 69 (29.6) 404 (43.2) 0.000 
 18   7 (0.6) 2 (0.9) 5 (0.5) - 
 20   113 (9.7) 25 (10.7) 88 (9.4) 0.539 
 22   6 (0.5) 2 (0.9) 4 (0.4) - 
 24   68 (5.8) 15 (6.4) 53 (5.7) 0.651 
 26   2 (0.2) 0 (00.0) 2 (0.2) - 
 28   57 (4.9) 15 (6.4) 42 (4.5) 0.216 
 30   2 (0.2) 0 (00.0) 2 (0.2) - 
 32   9 (0.8) 1 (0.4) 8 (0.9) - 
 Unknown   399 (34.1) 98 (42.1) 301 (32.1) - 
Placement site [n (%)]       
 Midaxillary   268 (22.9) 48 (20.6) 220 (23.5) 0.345 
 Anterior midclavicular  6 (0.5) 2 (0.9) 4 (0.4) - 
 Anterior axillary  30 (2.6) 5 (2.1) 25 (2.7) 0.650 
 Posterior axillary  391 (33.4) 63 (27.0) 328 (35.0) 0.020 
 Unknown   474 (40.5) 115 (49.4) 359 (38.4) - 
Indication [n (%)]       
 Malignancy   440 (37.6) 68 (29.2) 372 (39.7) 0.003 
 Trauma   195 (16.7) 39 (16.7) 156 (16.7) 0.979 
 Iatrogenic   19 (1.6) 3 (1.3) 16 (1.7) 0.649 
 Pneumothorax  158 (13.5) 33 (14.2) 125 (13.4) 0.747 
 Empyema or parapneumonic effusion 101 (8.6) 37 (15.9) 64 (6.8) 0.000 
 Effusion   166 (14.2) 32 (13.7) 134 (14.3) 0.820 
 Other   90 (7.7) 21 (9.0) 69 (7.4) 0.400 
Urgency [n (%)]       
 Elective   151 (12.9) 25 (10.7) 126 (13.5) 0.266 
 Urgent/emergency  1018 (87.1) 208 (89.3) 810 (86.5) 0.266 
One tube [n (%)]   1138 (97.3) 223 (95.7) 915 (97.8) 0.082 
Bilateral tube [n (%)]   31 (2.7) 10 (4.3) 21 (2.2) 0.082 
Ultrasound guided placement [n (%)] 26 (2.2) 4 (1.7) 22 (2.4) 0.557 
Tube time [mean (range)] days  6 (1-43) 11.1 (2-43) 5.0 (1-33) 0.000 
Hospital time [mean (range)] days  10 (1-111) 16.4 (2-111) 8.4 (1-70) 0.000 
 
 
Complications 
 
In this study, there were 289 complications in 233 patients (19.9%) after chest tube placement. The 
most common type of complication was positional in 96.5% of patients, meaning that the tube did 
not perform adequately during the treatment period. Only 1.7% of the complications were 
insertional complications and 1.7% of the complications were infective. Removal and 
instructional/educational/equipment related complications didn’t occur. In the present study, there 
was no perforation of an organ, bleeding requiring transfusion or intractable pain. 
In 66,8% of cases the positional complications were a need for a new tube and in 29.1% of cases 
operative intervention was needed to treat the underlying cause for which the tube was placed. A 
combination of need for operative treatment and a new tube occurred in 49 cases. There were 
altogether 103 deaths, none of which were attributable to the chest tube placement itself and all of 
them occurred later than 24 hours after tube insertion.  
Among the diabetic patients, complication types were distributed similarly to the whole population. 
51 diabetics had altogether 60 complications; 1 (1.7%) malposition, 17 (28.3%) need for operative 
intervention and 42 (70.0%) need for a new tube. 
 
Table 3. Complications 
     
Total complications [n]   289 
Total insertional complications [n]  5 
Insertional complications separately [n (% of total complications)] 
 Malposition   5 (1.7) 
 Perforation of an organ  0 
 Bleeding requiring transfusion 0 
 Intractable pain  0 
 Need for immediate operative intervention 0 
Total positional complications [n]  284 
Positional complications separately [n (% of total complications)] 
 Need for operative intervention 84 (29.1) 
 Need for new tube  193 (66.8) 
 Prolonged air leak  2 (0.7) 
Infective complications [n (% of total complications)] 5 (1.7) 
Removal complications [n (% of total complications)] 0 
Instructional/educational/equipment related complications [n (% of total 
complications)] 0 
 
On multivariable binary logistic regression, chest tube size CH16 was associated with a lower risk 
of complications (OR 0.22, 95%CI 0.10-0.52, p<0.001) and diabetes was associated with an 
elevated risk of complications (OR 1.86, 95%CI 1.28-2.70, p=0.001). 
 
 
Discussion 
 The main finding of this study is that although complications occur in 1 out of 5 patients receiving a 
tube thoracostomy, severe complications are infrequent.  
Tube thoracostomy is a frequent procedure; based on the present study the yearly incidence in 
Southwestern Finland is at least 28/100 000 inhabitants not including postoperative chest tubes and 
bedside tubes at intensive units (population of the catchment area approx. 460 000 inhabitants).(8) 
In spite of it being a staple procedure of acute medicine its complications have not been extensively 
studied. Most of the previous studies on the epidemiology of chest tube complications have 
described outcomes in trauma patients only.(4) (6) There exists few studies including patients 
treated with TT for non-traumatic indications.(9) The complication rates have been reported 
between 1-40% in previous studies depending on the definition of complications. Hernandez et al. 
found in their systematic review and meta-analysis that the TT complication rate for traumatic 
indications has been approximately 19% during the past three decades identical to our study.(6) In 
another study including patients treated with TT for any indication the complication rate has also 
been approximately 19%.(9) Based on the current study and existing literature the frequency of 
complications related to TT is quite high. The complication rate is similar to that seen in trauma 
patients although the patient population is quite different. The most common indication for the 
procedure was a primary or metastatic thoracic malignancy in 37.6% of patients and most of these 
were treated by a pulmonologist, with pulmonologist consequently being responsible for 40.5% of 
the chest tube placements. Malignancies as an indication have not been as frequent in other studies 
or it has not been defined as an indication itself.(9) 
 
Serious complications in the present study were, however, infrequent and no death was attributable 
to the chest tube placement. Nevertheless, 29.1% needed operative intervention, but operations 
were performed to treat the pre-existing condition for which the chest tube was placed, and no 
patient required surgery because of a complication related to the chest tube per se. There were 103 
deaths after tube placement, which were almost exclusively due to malignancy in the nearly half of 
patients who received a TT for malignant pleural effusion. 
98.3% of the complications occurred after 24 hours and only 5 patients had early complications, all 
of which were malpositions. In earlier studies the early complication rates have been higher. This is 
unlikely due to major differences in definitions as the classification of complications used in this 
study is quite similar to other studies.(2) (7)  
The most frequent complication was need for a new tube due to malfunction (for example 
occlusion) and the second most frequent complication was need for operative treatment. These two 
complications represented 95.9% of all complications and occurred in 19.5% of TT treated patients. 
This is clinically relevant and implies that some form of reintervention is to be anticipated during 
the hospitalization. Whether some tube malfunctions could be avoided by primary placement of 
large bore tubes is possible, but previous literature on the importance of tube diameter is 
conflicting; many studies show similar treatment failure rates for both small and large tubes and 
based on the existing literature for example the British Thoracic society advocates small size chest 
tubes as first line treatment for noninfectious indications. Most of the studies on size, however, are 
also retrospective and do furthermore do not fully adjust for the viscosity of the treated effusion and 
other patient specific factors.(10) (11) (12) The prospective randomized TIME study showed no 
difference in efficacy or complications between small and large tubes, although notably the study 
was no designed to assess complication rates.(13) Several studies, including one prospective 
randomized, specifically on malignant effusion have demonstrated similar results and complication 
rates irrespective of tube diameter.(14)(15)(16) In this study, small CH16 tubes were independently 
associated with fewer complications. These tubes were mostly inserted by pulmonologists (95.8%) 
and almost exclusively for malignant effusion. Consequently extrapolating the results to other 
indications should be made with caution. 
Diabetics were also more likely to experience a complication. The reason for this is unclear as the 
higher incidence of complications was not explained by a higher infection rate. Also, the indications 
were similar to the whole population in diabetics and the frequency of infective indications was 
even slightly lower (13,7% vs 15,9%). The most likely explanation is a type I error, but it could also 
be explained by a higher comorbidity burden in diabetics. This is possible especially as most of the 
diabetics had type II diabetes, alluding to obesity and other lifestyle –related factors that typically 
increase the frequency of postprocedural complications. Aside from diabetes, empyema or 
parapneumonic effusion as an indication for treatment was associated with complications. This is 
intuitive, as infective collections of the pleura are often viscous and adhesions are frequent, which 
entail a propensity for tube occlusion. Notably most studies advocating preference of small tube 
sizes for other indications still recommend large sizes for empyema and hemothorax. 
 
Infection was the only potentially serious complication directly caused by the tube in this study. 
Infections accounted for only 1.7% (5 cases) of the complications. Other serious complications 
primarily caused by the drain were nonexistent in the present study while the literature describes a 
large spectrum of possible complications.(9) (17)  
  
Limitations 
 
The study has all the limitations inherent in a retrospective registry-based study; incompleteness of 
data and lack of prospective data collection leading to possible missing data on preprocedural 
characteristics. Some minor complications might be missing, but complications requiring in-
hospital treatment are identifiable from procedural codes, medication charts and blood product 
reporting. Also, the information gained from this study cannot be directly applied to describe 
complication frequencies in patients receiving bedside or imaging guided chest tubes, which were 
not included in the present patient population. 
 
 
Conclusions 
 
Tube thoracostomy is a common procedure and complications occur in 19.9% of patients. Serious 
complications caused by the chest tube placement, however, are extremely rare. Complications 
were more common in diabetics and patients receiving a chest tube for empyema or parapneumonic 
effusion. Small CH16 tubes were associated with a lower incidence of complications but were also 
most frequently used for palliative care in cancer patients. Cases where tube thoracostomy is 
insufficient or malfunctioning the need for a new tube (16.5%) or operative intervention (7.2%) are, 
however, quite common and should be anticipated. 
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